Private Equity

US

Alumina to provide $25 mln to MYM Nutraceuticals

Alumina Partners has inked a term sheet to provide $25 million in funding to MYM Nutraceuticals Inc. Based in Vancouver, British Columbia, MYM Nutraceuticals Inc is an cannabis grower and nutraceuticals manufacturing and distribution company focused on global cannabis markets.

2 min read · 03 December 2018

Australis funds cannabis producer Quality Green

Ontario-based Quality Green, a licensed cannabis producer, has raised $2 million in funding. The investor was Australis Capital, an investment firm focused predominantly on the U.S. cannabis industry.

1 min read · 03 December 2018

Revive Solutions snags $3.4 mln seed

San Francisco-based Revive Solutions Inc, a developer of an automated external defibrillator, has raised $3.4 million in seed funding. Greenbox Venture Partners led the round with participation from other investors that included Rock Health, HealthTech Capital and Hippocrates VC.

1 min read · 03 December 2018

Sentryo raises 10 mln euros

Sentryo said Dec. 3 that it raised 10 million euros ($11.3 million) in a series A financing round. New investors include Sopra Steria, BNP Paribas Développement, Omnes and Alliance Entreprendre. Also participating were prior investors Breed Reply, ACE Management, and Kreaxi. Sentryo, of Lion, France, provides cybersecurity software.

6 min read · 03 December 2018

Video-based practice platform Rehearsal

Reno, Nevada and Germany-based Rehearsal, a video-based practice platform, has secured $2 million in funding. The investor was Cypress Growth Capital.

1 min read · 30 November 2018

Wave Computing lands $86 mln Series E

Silicon Valley-based Wave Computing, an artificial intelligence company, has raised $86 million in Series E funding. The lead investor was Oakmont Corporation.

1 min read · 30 November 2018

ViaCyte nabs $80 mln Series D

San Diego-based ViaCyte Inc, a privately-held clinical stage regenerative medicine company, has secured $80 million in Series D financing. The investors included Bain Capital Life Sciences, TPG and RA Capital Management.

1 min read · 30 November 2018

Aprea Therapeutics picks up Series C funding

Boston and Stockholm-based Aprea Therapeutics, a clinical-stage biotechnology company developing novel anticancer therapies targeting the p53 tumor suppressor protein, has secured 50 million euros in Series C financing. Redmile Group led the round with participation from Rock Springs Capital, 5AM Ventures, Versant Ventures, HealthCap, Sectoral Asset Management and Karolinska Development AB.

1 min read · 30 November 2018

Differential Ventures recruits Magerman as managing partner

Differential Ventures, a seed and early-stage venture firm, has named David Magerman as managing partner. Magerman is a former research scientist and head of production at hedge fund management firm Renaissance Technologies.

3 min read · 30 November 2018

Lentesplus.com inks $5 mln Series A

Lentesplus.com, an e-commerce platform for contact lenses in Latin America, has raised $5 million in Series A funding. The investors included Palm Drive Capital, IGNIA and InQlab.

1 min read · 29 November 2018

Showing 5,931 to 5,940 of 41,793 results
1…593595…1000